Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

6.41
Delayed Data
As of Apr 27
 -0.68 / -9.59%
Today’s Change
4.07
Today|||52-Week Range
12.88
-31.74%
Year-to-Date

Today’s Trading

Previous close7.09
Today’s open7.17
Day’s range6.34 - 7.20
Volume1,798,308
Average volume (3 months)915,294
Market cap$272.2M
Dividend yield--
Data as of 4:00pm ET, 04/27/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-6.81%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book3.25

Competitors

 Today’s
change
Today’s
% change
POZNPOZEN Inc-0.14-1.67%
PPHMPeregrine Pharmaceut...-0.03-2.53%
NHTCNatural Health Trend...+0.93+4.14%
ASMBAssembly Biosciences...-1.26-8.12%
Data as of 4:00pm ET, 04/27/2015

Financials

Next reporting dateMay 1, 2015
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers